Skip to main content

1 Result(s)

within Zhenzhen Hui Remove this filter Antibodies Remove this filter

and

  1. Article

    Open Access

    Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)

    The combination of immune checkpoint inhibitors (ICIs) with chemotherapy (chemoimmunotherapy) in the neoadjuvant setting have achieved favorable clinical benefits in non-small cell lung cancer (NSCLC), but the...

    Zhenzhen Hui, Jiali Zhang, Yulin Ren, **aoling Li, Cihui Yan… in Cell Death & Disease (2022)

    Download PDF (9268 KB) View Article